Kirill Dmitriev, CEO of the Russian Direct Investment Fund (RDIF) told that clinical trials of Sputnik V vaccine for coronavirus will begin in Saudi Arabia, United...
With several coronavirus vaccine candidates showing promise, the UN agency, in collaboration with the Revolving Fund of the Pan American Health Organization (PAHO), will lead efforts...
The World Health Organization says that none of the vaccine candidates have so far demonstrated a "clear signal" of efficacy against COVID-19
According to the results of Russia's 'Sputnik V' COVID-19 vaccine candidate published in The Lancet journal, most common adverse effects of the vaccine were pain at...
According to the researchers, global samples show SARS-CoV-2 to be less diverse than other viruses such as HIV, influenza and dengue. This may aid in the...
According to experts, the aim behind Covax (COVID-19 Vaccines Global Access Facility) is to prevent hoarding and focus on vaccinating high-risk people in every country
The blood samples collected from the volunteers who received the vaccine were to ascertain how effective the vaccine was in terms of the level of antibodies...
World Health Organisation's Chief Scientist Soumya Swaminathan said the focus needs to be on global collaboration when dealing with the virus diagnostics, therapeutics, transmission and vaccine...
The second phase trial of Oxford University and Serum Institute’s COVID-19 vaccine has begun in Pune, as the vaccine candidate administered to two volunteers at Bharati...
As per the experts, there are two pathways to herd immunity - natural infection, when a large number of people have had a disease and recovered;...
The Indian Council of Medical Research (ICMR), the country's top medical research body is working to create a vaccine portal, as a repository for all information...
Human trials for potential COVID-19 vaccine begin in India. A total of 1,600 eligible participants of more than or equal to 18 years of age will...
